Europeans warm to pharma info

Share this article:

A Manhattan Research survey found that “nearly two in five online Europeans would like to be able to learn more about prescription drugs directly from a pharmaceutical company,” with Italians most keen on interacting with pharmas and Germans least interested. Europeans cared less about getting online contests and games from pharmas than they did about practical resources like disease and treatment information or condition management tools. They were also largely disinterested in visiting pharma Facebook or Twitter pages.

The data are from Manhat­tan Research's Cybercitizen Health Europe 2011 survey of 3,020 adults in the UK, France, Germany, Italy and Spain.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?